Cross-cohort generalizability of machine learning models for early-stage node-negative breast cancer relapse prediction
Background: Adjuvant therapy decision in early-stage node-negative breast cancer remains one of the most challenging problems in oncology. Although most patients in this population achieve favorable outcomes with endocrine therapy alone, a subset remains at risk of relapse and may benefit from chemotherapy. Accurate id...